Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Clínica de Marly S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Col$8,500.00 |
52 Week High | Col$0 |
52 Week Low | Col$0 |
Beta | 0.068 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
3 Year Change | 32.81% |
5 Year Change | 60.38% |
Change since IPO | 300.23% |
Recent News & Updates
Recent updates
Shareholder Returns
MARLY | CO Healthcare | CO Market | |
---|---|---|---|
7D | 0% | -4.5% | -0.6% |
1Y | 0% | 15.2% | -0.5% |
Return vs Industry: MARLY underperformed the CO Healthcare industry which returned 15.2% over the past year.
Return vs Market: MARLY matched the CO Market which returned -0.5% over the past year.
Price Volatility
MARLY volatility | |
---|---|
MARLY Average Weekly Movement | 0% |
Healthcare Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in CO Market | 6.2% |
10% least volatile stocks in CO Market | 2.9% |
Stable Share Price: MARLY has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MARLY's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1903 | 837 | Luis Eduardo Castro | https://marly.com.co |
Clínica de Marly S.A. provides health services in Colombia. The company offers services in the areas of anesthesia, bronchoscopy, cardiology, bariatric surgery, column surgery, hand surgery, general surgery, maxillofacial surgery, plastic and reconstructive surgery, other surgery, pain clinic, coloproctology, palliative care, dermatology, endocrinology, physiatry, gastroenterology, gynecology, hematology, diagnostic imaging, infectology, and neurodiagnostic and pathology laboratory. It also provides vascular laboratory non-invasive method, internal medicine, nephrology, neonatology and pediatrics, pneumology, functional and restorative neurosurgery, neurology, ophthalmology, clinical oncology, orthopedics and traumatology, otorhinolaryngology, psychiatry, rheumatology, bone marrow transplant, intermediate and intensive care unit, outpatient chemotherapy, clinical laboratory, maternal fetal medicine unit, emergency, and urology, as well as digestive physiology laboratory services.
Clínica de Marly S.A. Fundamentals Summary
MARLY fundamental statistics | |
---|---|
Market cap | Col$90.76b |
Earnings (TTM) | Col$62.14b |
Revenue (TTM) | Col$349.93b |
1.5x
P/E Ratio0.3x
P/S RatioIs MARLY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MARLY income statement (TTM) | |
---|---|
Revenue | Col$349.93b |
Cost of Revenue | Col$223.12b |
Gross Profit | Col$126.81b |
Other Expenses | Col$64.67b |
Earnings | Col$62.14b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 5.82k |
Gross Margin | 36.24% |
Net Profit Margin | 17.76% |
Debt/Equity Ratio | 2.5% |
How did MARLY perform over the long term?
See historical performance and comparisonDividends
9.2%
Current Dividend Yield14%
Payout RatioDoes MARLY pay a reliable dividends?
See MARLY dividend history and benchmarksClínica de Marly dividend dates | |
---|---|
Ex Dividend Date | Apr 04 2024 |
Dividend Pay Date | Apr 10 2024 |
Days until Ex dividend | 7 days |
Days until Dividend pay date | 13 days |
Does MARLY pay a reliable dividends?
See MARLY dividend history and benchmarks